Ortho-Cyclen

DRUG4 trials

Sponsors

Agile Therapeutics, Eli Lilly and Company, ViiV Healthcare

Conditions

Diabetes Mellitus, Type 2HealthyHealthy VolunteersInfection, Human Immunodeficiency Virus

Phase 1

AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

CompletedNCT01243580

Agile TherapeuticsHealthy

Start: 2009-08-31End: 2009-12-31Updated: 2018-01-23

A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

CompletedNCT01458210

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2011-10-31End: 2012-02-29Updated: 2014-10-08

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

CompletedNCT01498861

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2011-12-31End: 2012-03-31Updated: 2012-05-21

A Study of Evacetrapib in Healthy Female Participants

CompletedNCT01746732

Eli Lilly and CompanyHealthy Volunteers

Start: 2012-12-31End: 2013-05-31Updated: 2018-10-09

Related Papers

Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model

PLoS ONE2022-12-274 citations

No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide.

2017-11-0118 citations

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.

2011-11-3018 citations